I Abstract lmmunoassays are commonly used to screen samples prior to confinnation by gas chromatography-mass spectrometry (GC-MS). This serves two purposes: it provides a second method for positive samples, and it allows exclusion of negative samples from further confirmatory testing, In addition, immunoassay results can be used in some cases to determine if dilution of the sample will be required during the confirmatory assay. We used 878 sweat patches worn by 38 subjects receiving treatment for cocaine dependence to compare analysis of the extracts of the patches for cocaine immuno-equivalents by radioimmunoassay (RIA) with detennination of cocaine, benzoylecgonine (BE), and ecgonine methyl ester (EME) by GC-MS. Preliminary validation experiments demonstrate that the GC-MS method using positive ion chemical ionization had sufficient specificity and recovery to support a lower limit of quantitation (LLOQ) of 4 ng!patch and was precise and accurate across a linear range up to 500 ng!patch. Cocaine ranging from the llOQ to 31,900 ng!patch was found in 660 of the samples; BE ranging from the LLOQ to 3470 ng!patch was found in 530 of the samples; and EME ranging from the LLOQ to 2280 ng!patch was found in 476 of the samples. In a subset of 238 samples semiquantitative use of the RIA gave results that agreed with GC-MS with a correlation coefficient of 0.986, but averaged approximately 23% lower. Although this accuracy of the RIA supported its use as a sole quantitative assay, the limited linear range of the RIA (4-200 ng!patch) proved impractical for this purpose. Receiver operator characteristic analysis of the cutoffs of the RIA and GC-MS suggested optimal cutoffs of 5 and 4 ng!patch, respectively. At these cutoffs, the RIA had sensitivity of 90.0% and specificity of 92.2%. For samples that had RIA results greater than the high calibrator (N = 228), various dilution schemes were assessed for their ability to predict retention of either cocaine alone or cocaine and both metabolites within the linear range of the GC-MS. When cocaine was the only analyte of interest, a single 20·fold dilution retained 200 (87.7%) of the samples. This compared to an optimal scheme where a different dilution was selected for each one-tenth ratio(< 0.1, 0.1~.2, etc.) where 211 (92.5%) of the samples were retained. When trying to retain cocaine and both metabolites, dilution schemes were less successful as BE and EME would often fall below the LLOQ of the GC-MS. A single fivefold dilution of all samples retained 115 (50.4%) compared to an optimum of 143 (62.7%). The optimum could be approached with four dilution sets retaining 142 of the samples. Time expended on perfonning RIA analysis of all the samples was cost-· effective when the results were used to exclude negatives from and predict dilutions required for GC-MS anal ysi. s. RIA offers a cost-effective, sensitive, and specific alternative initial test for cocaine determination in extracts of sweat patches.
Introduction
The human body eliminates drugs of abuse through various routes. Sweat is a signifi cant route of elimination of primarily, basic drugs (1) . Sample collection has been one of the limiting factors in the analysis of sweat in drug abuse studies. The use of occlusive (i.e., non-permeable) patches containing absorbant material has allowed for the collection and detection of drugs of abuse such as amphetamines (2, 3) , methadone (4}, phenobarbital (5), phencyclidine (6) , and cocaine (7) . Because patches do not allow the passage of water, disadvantages included a change in the matrix environment and irritation for the wearer (8) that limited the duration of patch application.
The development of a non-occlusive patch allowing water and smaller volatile molecule passage provided for p:olonged patch attachment to subjects. This type of patch has been used in a number of studies for the determination of cocaine and metabolites (9) (10) (11) (12) (13) (14) , opiates (9, 12, (15) (16) (17) (18) , amphetamines (19, 20) , phenobarbital (15) , benzodiazepines (21) , nicotine (22}, and general drug use in opiate users under treatment with b up rmorphine (23) . Sweat patch usage has been advocated for circumstances involved in monitoring cumulative drug use over a period of a week(s), including substance abuse treatment and the criminal justice system programs.
Sweat may also be useful for other types of forensic or workplace investigations utilizing spot test methods. One recent apprmch included the use of onsite testing with the I:rugwipe testing device, which has been found to be suitable for detection of cocaine (24) , opiates (25) , and amphetamines (26) . Altern alively, liquid perspiration can be collected directly upon stimulation with pilocarpine using the Macroduct device. This collection system uses pilocarpine iontophoresis to stimulate p reduction of liquid perspiration, which is then harvested into microboretubing coiled within the collector. In a comparison of collection of liquid perspiration using this device to urine and sweat patch collections, the Macroduct device was equally as sensitive as the patch for detection of the SAMSHA 5-mandated drugs of abuse. Also, both sweat testing methods were slightly more sensitive than urine testing (27) . Whereas both the Drugwipe and Macroduct devices offer the advantage of spot testing, the latter also provides for direct collection of liquid perspiration allowing for results to be reported in amounts per milliliter liquid perspiration; an important element in determining the pharmacokinetics of drug elimination through sweating. A basic principle of forensic drug testing is the use of two distinct methods with cliff e rmt chemical techniques to identify a drug, or drug group, of interest (28, 29) . When immunoassays exist for the drug in question, use of mass spectrometry in combination with the immunoassay is a common approach (28) (29) (30) . A number of the studies ref e rmced here have compared a microplate enzyme-immunoassay (EIA) to gas chromatography-mass spectrometry(GC-MS) for the detection of cocaine and metabolites (11) (12) (13) , opiates (16, 18) , and amphetamines (19) . In addition, Kidwell et at. (14) recently compared two other micro-plate immunoassays and a modified CEDIA immunoassay to GC-MS for detection of cocaine in patch extract. Both Burnes et al. (10) and Moody and Cheever (31) have shown that a radioimmunoassay (RIA) can detect cocaine and/or metabolites (cocaine immuno-equivalents) in extracts of sweat patches. At this time, 878 patches worn by individuals re. ceiving treatment for cocaine use have been analyzed Analysis was perfo rrred using a GC-positive ion chemical ionization (PICI)-MS method for cocaine, benzoylecgonine (BE), and ecgonine methyl ester (EME) (32) , and RIA (31) . The sensitivity and specificity of the RIA were compared at various cutoff levels; the ability of the RIA result to predict dilution requirements for GC-MS analyses we recalculated, and for a subset of the samples the quantitative accuracy of the RIA was detennined.
Methods

Materials
Cocaine, BE, and EME (both d 0 and d 3 ) were purchased from Radian (now Cerilliant, Austin, TX) as free base solutions. Cocaine hydrochloride was also purchased from Sigma Chemical Co. (St. Louis, MO). Pharm Chek® drugs of abuse patches were purchased from Pharm Chern Laboratories (Palo Alto, CA). Polypropylene vials (5 mL) for extractions were purchased from VWR Scientific Products (Salt Lake City, UT). The Cocaine Metabolite Coat-A-Count RIAs were purchased from Diagnostic Products Corporation (Los Angeles, CA). Hexafluoroisopropanol and pentafluoropropionic anhydride were purchased from Aldrich Chemical Co. (Milwaukee, WI) and Regis Technology (Morttn Grove, IL), respectively. Glacial acetic acid was obtained from Sigma (St. Louis, MO), and sodium hydroxide, hydrochloric acid, and dibasic and monobasic potassium phosphate were from Mallinckrodt, Inc. (St. Louis, MO). The GC column was a DB-1 (15 x 0.32-mm, 1-pm film thickness) fused-silica capil larycolumn obtained from J&W Scientific (Folsom, CA).
Clinical study
Sweat patches were worn by subjects participating in a clinical trial testing the effectiveness of methylphenidate treatment of cocaine users diagnosed with attention deficiency disorder. This study was carried out at three Veterans Administration Medical Centers: Cincinnati (Drs. Eugene Somoza and Theresa Winhusen, Principle Investigators), Boston (Drs. L. Awad and Dominic Ciraulo, Principal Investigators), and New York City (Dr. D. Vanderburg Principal Investigator). The general design involved subjects wearing a patch on both the right and left arms concurrent I y, with replacement of the right arm patch every 2-3 days and the left arm patch every 7 days, with subjects wearing patches continuously for approximately 2 months. Thirty-seven subjects wore a total of 1-39 patches (mean= 23.8, median= 29, total = 879). Of these, 0-29 patches were on the right arm (mean = 17.2, median = 20, total= 638) and 1-11 were on the left arm (mean= 6.5, median= 8, total = 241). Subjects wore patches continuously for 1-71 days (mean = 48.2, median = 62). Individual patches on the right arm were typically worn for 2 or 3 days with some variations (range 0.5-18; mean = 2.6, median= 2 days); individual patches on the left arm were typically worn for 7 days with some variations (range 1-22; mean= 6.3; median= 7 days). Details of the study protocol are subject of a larger study (33) . Patches were placed and removed using the previously described protocol of the manufacturer (11) (12) (13) 16, 18, 19) . Patches were stored at approximately -20°C until analysis.
Preparation of calibrator and quality control patches Stock solutions in methanol of 100 pgtmL of cocaine, 100 pgtmL BE, and 100 pgtmL EME were used to prep a reworking solutions that contained either 0.1 pgtmL or 1.0 pgtmL each of cocaine, BE, and EME or cocaine only in Milli-Q water. For GC-MS analysis, calibrator and control working solutions contained all three analytes. For RIA, calibrator and control working solutions contained only cocaine.
After removing the packaging, the patches were labeled and placed adhesive side up on clean terri-towels. The aprropriate amount of working solution was applied to the absorbent pad using calibrated pipetmans and the patches were allowed to dry for at least 1.5 h. The absorbent pad was then removed from the adhesive layer with forceps and rolled up with a wooden application stick. The rolled pad was then placed into the 5-mL polypropylene vial, the vial capped and stored at -20°C until analysis.
Extraction of patches
Patches were extracted as described by the manufacturer. 1Wo and one-half milliliters of extraction buffer [methanol/0.2M sodium acetate (pH 5), 75:25, vlv) was added to each extraction vial. The tubes were re-capped and placed on an orbital shaker for 30 min. Extract was taken directly from these vials for further analysis.
RIA
The RIA analysis was perf o nred using the previously described modification of the manufacturer's procedure (31) , where 1.0 mL of Jl25.tracer was first added to antibody-labeled Coat-A-Count tubes, followed by 100 ~L of sample. The tubes were allowed to incubate for 2 h, the contents decanted and the tubes counted on a Cobra gamma counter (Packard Instrument Co., Meridan, CT). Calibrators were run in duplicate at4, 5, 10, 20, 50, 100, 150, and 200 nglpatch with QCs run in triplicate at 4, 50, and 100 nglpatch. Quantitation was performed using the four-point logistic curves. The RIA has stated crossreactivities of 104% for BE at 433 nglmL; 4291, 3918, and 4002% for cocaine at 1, 10, and 100 nglmL, respectively; and 4.8 and 5.7% for EME at 5000 and 10,000 nglmL. • Average oiS blank patches that were extracted, fortified with tnternal standard, processed and any ion current at lhe retention time of the analyte compared to the l l OQ. 1 Comparison of d0 analyte added before and after total processing; results are the average from 10, 50 and 100 nglpatch, each at a replicate o( 5. GC-MS A 1-mL aliquot of the patch extract (less for reanalysis of samples that were greater than the upper limit of quantitation (ULOQ) of 500 nglpatch) was fortified with 100 ng each of the in terral standards, cocaine-d 3 , BE-d 3 , and EME-d 3 . The mixture was acidified with 4 mL of O.lM acetate buffer (pH 4.0), and solid-phase extraction (SPE) was performed as previously described (34) . The eluates were than derivatized with hexafluoroisopropanol and pentafluoropropionic anhydride and analyzed by GC-MS as previously described (32) . Calibrators at 4, 5, 10, 20, 50, 100, 200, 350, and 500 nglpatch and triplicate QCs at 10, 50, and 100 nglpatch were included in every batch.
Results and Discussion
Perfo rmance characteristics of GC-MS with sweat patch extracts
The GC-MS pocedure for quantitation of cocaine, BE, and EME was originally validated for analysis of human plasma (32) . Before proceeding with the analysis of sweat patch extracts, the method was cross-validated for this matrix (Table I) . Specificity was determined from analysis of five extracts of patches containing internal standard only (blanks) compared to t h reepatches fortified at the lower limit of quantitation (LLOQ) of 4 nglpatch. Average peak-area ratios of the blanks at the ion current profiles of the analytes did not exceed 12% of the peak a rea ratios of the LLOQ (Table 1) . Calibration curves were linear (mean r 2 0.996) from the LLOQ of 4 nglpatch up to the ULOQ of 500 nglpatch. Intra-(N = 5 within a batch) and interrun (means for five batches) accuracies were within 17.596 at the LLOQ and within 15.696 at other concentrations. Intraand interrun precisions were within 15.5%. The method requires a two-step extraction, first the patch, followed by SPE of the patch extract Recovery of drug was found to be excellent from extraction of the patch, but relatively low (31-34%) overall. The latter could be attributed to low recoveryfrom the SPE. This differed from previous experience with SPE of plasma, where average recoveries of these cocaine, BE and EME ranged from 76 to 88% (32) . It is speculated that the high methanol concentration in the patch extract might have reduced the extraction efficiency of the SPE method. This can be supported by the findings of Huestis et al. (12) , where use of a similar SPE method but extraction of patches with aqueous acetate buffer (pH 4.0) achieved average recoveries of 97, 60, and 93% for cocaine, EME, and BE, respectively. The low recovel)l however, was associated with very clean samples. It, therefore, did not affect achievement of an LLOQ (4 nglpatch or 1.6 nglmL extract) that is similar to those used in other studies on the detection of cocaine and metabolites in sweat patches (9, (11) (12) (13) .
Analytical approach
At the beginning of the study, all patches were subjected to GC-MS and semiquantitative RIA. It was soon noted, however, that the concentrations of analytes were exceeding the ULOQs for both methods for a large proportion of the samples and that reanalysis would be required Thereafter, the RIA was used only in a qualitative fashion. For some samples GC-MS was done first, allowing dilution of some of the high concentration sweat patch extracts prior to RIA. As a result, 878 samples were analyzed by both methods (Thble II). These samples will be the subject of the qualitative comparison of the two methods. Of these, 228 had RIA results greater than the high calibrator (Table II) . The RIA and GC-MS results for these samples were assessed to determine a dilution paradigm based upon the RIA result that would minimize the number of reanalyses required for GC-MS. Semiquantitative results greater than the cutoff were obtained for 238 samples (Table II) . These included many high concentration samples that were reanalyzed by RIA after dilution. These samples were used to compare the analytical accuracy of the RIA to GC-MS.
GC-MS findings
Six hundred and seventy eight of the patches contained one Quantitated by RIA and GC-MS > 4 ng cocaine/patch 238
• Sample was inadve<tently omitted from RIA batch. (Table III) . The relative appearance of EME and BE in these patches differs from previously published data by Cone et al. (9), who gave contrdled low doses of cocaine to subjects and applied patches for up to 72 h. In their findings, EME was present more often than BE, and when both were present, EME was generally found at higher concentrations than BE. This diff e renee could be attributed in part to the duration of patch application in this study. BE may become a more predominant metabolite than EME as time of patch application increases. Indeed, when the ratio of BE to EME was evaluated based upon duration of patch application, the following was found: s 1 day, BEIEME = 0.76 (n = 36); 2 days, BEIEME = 0.97 (n = 139); 3 days, BEIEME = 0.98 (n = 90); 4-{) days, BEIEME = 0.98 (n = 101); and 2: 7 days, BE/EME = 1.15 (n = 96). In support of this, Preston et al.
(13), who monitored methadone maintenance patients with patches worn for a week, also found BE concentrations slightly higher than EME.
Quantitative comparison of GC-MS and RIA
For 238 samples, quantitative RIA results greater than the LLOQ were obtained. These ranged in concentration from the LLOQ to= 7500 ng/patch. When these results were compared to those obtained by GC-MS for cocaine, a very good correlation (r = 0.986) was found ( Figure 1 ). The RIA, however, tended to give lower results than the GC-MS as the slope (RIA/GC-MS) for comparison was 0.77. Although an explanation for this dis- c repancy cannot be found, the results do support previous findings that RIA analysis can provide relatively accurate semiquantitation of cocaine in extracts of sweat patches (31) .
Evaluation of all patches in this mode was not performed, and therefore determination of the exact number of dilutions required to get all patch extracts within the linear range of the RIA was not achieved. The finding, however, suggests that the combination of the wide range of cocaine concentrations and the relatively small linear range of the RIA would make quantitative use of the RIA a tedious approach requiring too many dilutions to be a practical replacement for quantitative GC-MS.
Qualitative comparison of GC-MS and RIA
The sensitivity and specificity of the RIA was determined for RIA cutoffs of 4, 5, and 10 ng of cocaine immuno-equivaIents/patch compared to GC-MS cutoffs of 4, 5, 10, and 25 ng cocaine/patch (Table IV) . Whereas previous studies comparing GC-MS to the microplate EIA have only used a single GC-MS cutotf(the LLOQ) (11) (12) (13) (14) 16, 18, 19) , it was decided that additional assessments of varying GC-MS cutoffs would be included. This information may be valuable, as cutoffs applied to sweat patch testing may be determined based not on the technical limits of the quantitative method, but on the comparative sensitivity of sweat patches to a reference method, such as urine testing (14, 33) .
In all cases, as the RIA cutoff increased relative to any GC-MS cuto~ the number of false positives decreased and there I ate d value, specificity, increased. Conversely, as the RIA cutoff increased, the number of false negatives increased, and the related value, sensitivity, decreased ( Table IV) . As suggested by Spiehler et al. (11) , receiver operator characteristics were used to determine an optimal pair of cutoffs (Figure 2 ). In this method, "sensitivity" is plotted against "1-specificity". The ordinate that
Journal o( Analytical Toxicology, Vol. 28, March 2004 is closest to the nadir (where "sensitivity" = 1 and "1 -specificity" = 0) is considered optimal. This can be determined quantitatively by solving for the hypotenuse of a right triangle using "1 -sensitivity" and "1-specificity" as the distance of the two sides of the triangle (Figure 2 ). This shows that the optimal cutoffs would be 5 nglpatch for RIA and 4 nglpatch for GC-MS. Under these conditions, the sensitivity of the method is 90.0% and specificity is 92.2%. 1\vo other studies have compared a comparable number (> 500) of immunoassay to GC-MS results in detection of cocaine in extracts of Pharm Chek sweat patches (11, 13) . Both used the microplate EIA as the immunoassay, but they differed in sample population. Spiehler et al. (11) analyzed 501 patches, 275 (54.9%) of which were positive at a GC-MS cutoff of 10 nglpatch. Preston eta!. (13) analyzed 591 patches, 499 (84.4%) of which were positive at a GC-MS cutoff of 12.5 nglpatch. In the current study, 878 patches were analyzed, 659 (75.1%) of which were positive at a GC-MS cutoff of 4 ng!patch (note: at a more comparable GC-MS cutoff of 10 nglpatch, 583, 66.4%, we repositive in the current study). The sensitivity of the RIA at the optimal pair of cutoffs (90.0%) was somewhat less than that found for the microplate EIA in both studies (93.6 and 94.5%), although the specificity was comparable to the Preston eta!. (13) In this study, almost 25% of the samples had one or more ana lyles at a concentration greater than the ULOQ of the GC-MS calibration c u ne. Accurate measurement of these samples required reanalysis using a smaller aliquot. Often, determination of the proper aliquot size to use was not correct, requiring even further analysis. The potential use of initial test results to help determine the proper dilution may allow for more efficient analysis. In are trospective manner, the RIA results were evaluated to assess their usefulness in determining a proper dilution for the GC-MS analysis. • True positives 1\ad cocaine at coocefllr.Jtions wtolf for both GC-MS and RIA. 1 False positives had cocaine at coocentrations <cutoff for GC-MS. but cutoll for RIA.
Various Cutoffs
• False negatives had cocaine at concentrations cutoff for GC-MS, but <cutoff(()( RIA. I True negatives had cocaine at concentrations < w toll for both GC-MS and RIA.
• Sensitivity = true positives/(lrue positives + false negatives) x 100%.
" Specifocity = true negatives/(true negatives+ false posilives) x 1 00%. An evaluation of samples (N = 228) was performed on the RIA results that exceeded the high (200 ng/patch) RIA calibrator. These results were expressed as ratios to the high calibrator using 8/BI)S, and further divided into was prepared with ratios on one axis and the dilutions on another. This matrix was then filled with the number of samples having that ratio that would remain within the linear range of the GC-MS with that dilution. This was done using only cocaine results, as well as using cocaine, BE and EME results. In the situation with multiple analytes, it was more common that a dilution would cause the BE or EME results to be less than the LLOQ of the curve.
When cocaine was the only analyte evaluated, it was found that a single 20-fold dilution resulted in 200 (87.7%) of the diluted samples falling within the linear range. A more favorable result could be obtained by increasing the number of dilution sets used ( Figure 3A) . For example, a two-dilution-set model of diluting samples with ratios from< 0.1 to 0.4 30-fold and samples with ratios from 0.4 to 1.0 10-fold would result in 206 (90.3%) of the samples falling within the linear range. The optimal number of dilution sets, with cocaine as the only analyte, was 10, which resulted in 211 (92.5%) of the samples falling within the linear range ( Figure 3A ). This optimum was closely approached, however, with the use of four dilution sets ( < 0.1-0.4 ratios diluted 30-fold, 0.4-0.6 ratios diluted 20-fold, 0.6-0.9 ratios diluted 5-fold, and 0.9-l.O ratios diluted 10-fold) 209 samples fell within the linear range. Figure 3B shows the percent of samples within these four dilution sets that fell within the linear range at the different dilutions evaluated. Arguably, the increase in samples falling within the linear range from a single dilution to 4, or even 10, was minimal with cocaine as the only analyte.
When retention of the two metabolites and cocaine within the linear range was also an objective, increasing the number of dilution sets appears more valuable ( Figure 3A) . With a single dilution, only 115 {50.4%) samples would fall within the linear ranges for all three analytes. This increased to a maximum of 143 (62.7%) with a 10-dilution-set model, but this maximum was approached with a 4-dilution-set model ( < 0.1 ratios diluted 20-fold, 0.1-0.3 ratios diluted 10-fold, 0.3-0.6 ratios diluted 4-fold, and 0.6-1.0 ratios not diluted) that permitted 142 (62.3%) of the samples to remain in the linear ranges of all th rre analytes. Figure 3C shows the percent of samples within these four dilution sets that fell within the linear range at the different dilutions evaluated.
Cost-savings of inclusion of RIA
In this study, we have analyzed 878 extracts of sweat patches using both quantitative GC-MS and qualitative RIA. The importance of combining the two assays can be viewed from t\vo perspectives. For forensic analysis, it is optimal to test a sample with two methods that differ in their principal of analysis. The RIA provided results in agreement with GC-MS of ~icient percentage to be considered valuable for this purpose. Altern atively, the RIA could be employed as a screen to reduce the number of GC-MS analyses allowing for exclusion of negatives, and determination of dilution factors.
To determine if RIA provided sufficient cost-savings as compared to simply doing all of the assays by GC-MS the following steps were performed: 1. calculation of the effort required for analysis of a batch of samples by RIA or GC-MS; 2. determination of the number of samples requiring analysis using only GC-MS or using exclusion of RIA negatives and samples which no longer had to be repeated due to proper dilution; and 3. determination of the total effo rtneeded to analyze all of the samples. Effort was calculated relative to a single pay schedule, the laboratozytechnician equivalent (LTE). Calculations considered the situation of whether only cocaine or cocaine, BE, and EME we rebeing determined by GC-MS.
Both RIA and GC-MS re qui resarnple preparation, which in- eludes aliquotting for RIA, and aliquotting and extraction for GC-MS. The amount of time for RIA analysis includes the addition and incubation of reagents, and data reduction; for GC-MS analysis, the amount of time includes daily maintenance, instrument preparation, loading and initiating analytical runs and data reduction. Certification and QC review of RIA data are less time consuming than the same tasks for GC-MS. W th all of these factors taken into consideration, it was determined that analysis required 1.34 and 2.81 LTEs to analyze a batch of samples by RIA and GC-MS,respectively. The number of samples requiring analysis is the sum of initial analysis and the number of'> curve' repeat analyses minus excluded RIA negatives. For this study, these were 1085, 686, and 771 analyses for GC-MS only, GC-MS and RIA with determination of cocaine only, and GC-MS and RIA with determination of cocaine, BE, and EME, respectively. The methods allow RIA batch sizes of 85 samples and GC-MS batch sizes of 50 samples. With all of these taken into consideration, the total effort expended would be 61.0, 53.4, and 58.2 LTEs to analyze all samples for GC-MS only, GC-MS and RIA with determination of cocaine only, and GC-MS and RIA with determination of cocaine, BE, and EME, respectively. Therefore,if cocaine is the only analyte of interest, then combining RIA with GC-MS would not only provide forensically defensible results, but also save 7.5 LTE working days to complete a study of this magnitude. A cost savings of only 2.9 LTE working days would be realized if cocaine and the metabolites BE and EME were all being determined.
Conclusions
Our previously described GC-PICI-MS method for determination of cocaine, BE, and EME in human plasma can be applied to accurate and precise analysis of extracts of sweat patches. In the study population that wore the patches, cocaine was consistently found in higher concentrations than BE and EME, which were found in near equivalent concentrations. RIA gave semiquantitative results that correlated well with GC-MS, but averaged 20% lower. The smaller I in ear range of the RIA along with the wide range of cocaine concentrations suggested that use of RIA alone to obtain semiquantitative results would not be cost effective. As a qualitative screen the RIA had reasonable sensitivity and specificity at optimal cutoffs of 5 ng/patch for the RIA and 4 ng/patch for GC-MS. Furthermore, RIA results expressed relative to the high RIA calibrator were useful in determining dilutions to apply to samples being prepared for GC-MS. When cocaine was the only analyte of interest, applying a dilution of 20-fold to all of these samples was near optimal and combined with precluding RIA negatives from further analysis, was a cost effective use of the R1A. When results for cocaine and its metabolites, BE and EME, were also obtained, the use of four dilution sets was closer to optimal, however, even when combined with precluding RIA negatives from further analysis, inclusion of the RIA was less cost effective. When forensic analyses require use of two methods, or when confirmation analysis is for cocaine only, the RIA offers an alternative to microplate EIA for analysis of extracts of sweat patches.
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